Inex Pharmaceuticals Corp (IEX-T) Stock Predictions - Stockchase
WATCH LIST
11
Inex Pharmaceuticals Corp (IEX-T)

ON STOCKCHASE SINCE May 2001

anti cancer

biotechnology/pharmaceutical

Inex Pharmaceuticals Corp

IEX-T

0 watching          
Join the Discussion

Inex Pharmaceuticals Corp (IEX-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about IEX-T



  • All
  • Filtered
Signal Opinion Expert
COMMENT
This is a penny stock and they tend to be promoted.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
This is a penny stock and they tend to be promoted.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Kenneth P. Norq

Partner, Castlemoore Inc....

Price Price
$1.100
Owned Owned
No

BUY
A well-run company. Probably one of the lower risk biotech investments in Canada. Their product Onco TCS should be approved this year. Have a good marketing partnership with Enzon.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A well-run company. Probably one of the lower risk biotech investments in Canada. Their product Onco TCS should be approved this year. Have a good marketing partnership with Enzon.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ed Ho

Portfolio , Dynamic Mutual Funds...

Price Price
$7.430
Owned Owned
Unknown

BUY
If you like biotechs, this could be OK. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
If you like biotechs, this could be OK. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$4.550
Owned Owned
Unknown

DON'T BUY
Need to get FDA approval. Too speculative for their funds.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Need to get FDA approval. Too speculative for their funds.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Baskin

President, Baskin Wealth Manage...

Price Price
$3.690
Owned Owned
Unknown

HOLD
Good cash balance. Their problemsare delays in getting their product to market. Needs a good partner.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good cash balance. Their problemsare delays in getting their product to market. Needs a good partner.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Mike Weir

Managing D, Guardian Capital...

Price Price
$3.770
Owned Owned
Unknown

BUY
Needs approval by FDA. Nice cash balance.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Needs approval by FDA. Nice cash balance.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Mike Weir

Managing D, Guardian Capital...

Price Price
$4.140
Owned Owned
Unknown

DON'T BUY
There will be some delay in their filings with FDA.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
There will be some delay in their filings with FDA.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$4.900
Owned Owned
Unknown

WEAK BUY
In phase 3 trials. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
In phase 3 trials. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Cooper

Portfolio , T.D. Asset...

Price Price
$6.500
Owned Owned
Unknown

PAST TOP PICK
(Was a top pick on Dec 5 no change) Still likes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Was a top pick on Dec 5 no change) Still likes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Martin Hubbes,

Executive , AGF Funds Inc....

Price Price
$7.150
Owned Owned
Unknown

TOP PICK
A speculative choice, but has a good RISK/RETURN.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A speculative choice, but has a good RISK/RETURN.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Martin Hubbes,

Executive , AGF Funds Inc....

Price Price
$7.550
Owned Owned
Unknown

BUY
Just partnered which is good. Good company
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Just partnered which is good. Good company
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Malvin Spooner

Chairman a, Mavrix Fund Manageme...

Price Price
$6.700
Owned Owned
Unknown

Showing 1 to 11 of 11 entries
Successfully Saved Company
Successfully Saved Company